Answers are grounded in this paper and cite their sources.
Stroke-associated pneumonia (SAP) is a frequent and severe complication of acute ischemic stroke (AIS). This study aimed to evaluate the predictive value of the low-grade inflammation score (INFLA-score), a composite inflammatory marker, for the development of SAP in AIS patients. We retrospectively analyzed data from 692 patients with AIS. The INFLA-score was calculated based on the deciles of white blood cell (WBC) count, platelet (PLT) count, neutrophil-to-lymphocyte ratio (NLR), and high-sensitivity C-reactive protein (hs-CRP). Multivariable logistic regression was used to identify independent risk factors for SAP. We compared the predictive performance of the INFLA-score with that of traditional inflammatory markers, including NLR, platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). Predictive performance was compared using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Clinical utility was assessed using decision curve analysis (DCA). Of the 692 patients, 164 (23.7%) developed SAP. Multivariable analysis showed that a higher INFLA-score was an independent predictor of SAP (OR = 1.180, 95% CI: 1.132–1.233, p < 0.001). The AUC of the INFLA-score (0.777) was significantly higher than those of NLR (0.631), PLR (0.658), and MLR (0.641) (all DeLong p < 0.001), yielding a substantial reclassification gain. Furthermore, incorporating the INFLA-score into the baseline A2DS2 model significantly enhanced the predictive performance, with a significant net reclassification improvement (NRI = 0.163, p < 0.001) and integrated discrimination improvement (IDI = 0.114, p < 0.001). Restricted cubic spline analysis showed a positive association between the INFLA-score and SAP risk, with no evidence of nonlinearity ( p for nonlinearity = 0.428). DCA curves demonstrated high clinical net benefit for the integrated model. The INFLA-score is a robust and independent predictor of SAP in AIS patients. The score showed better discrimination than traditional inflammatory ratios and may improve early SAP risk stratification, pending external validation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: